Xylem Inc.
XYL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 1.06 | -0.90 | 0.43 |
| FCF Yield | 0.78% | 0.66% | -0.13% | 1.68% |
| EV / EBITDA | 82.63 | 71.60 | 81.40 | 55.68 |
| Quality | ||||
| ROIC | 1.69% | 1.51% | 1.22% | 1.62% |
| Gross Margin | 38.93% | 38.77% | 37.12% | 37.99% |
| Cash Conversion Ratio | 1.59 | 1.35 | 0.20 | 1.76 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.62% | 12.96% | 14.69% | 15.74% |
| Free Cash Flow Growth | 35.75% | 644.74% | -108.00% | 100.42% |
| Safety | ||||
| Net Debt / EBITDA | 1.74 | 2.11 | 2.91 | 1.91 |
| Interest Coverage | 55.67 | 33.89 | 28.88 | 29.67 |
| Efficiency | ||||
| Inventory Turnover | 1.34 | 1.32 | 1.27 | 1.40 |
| Cash Conversion Cycle | 75.90 | 73.38 | 80.25 | 65.90 |